Prevalence, risk factors, and management of prehypertension

International Journal of Hypertension

Volumn 2011, Issue , 2011, Pages

  Zhang, Wenwen ^a   Li, Ninghua ^a  

^a BEIJING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CANDESARTAN HEXETIL; PLACEBO;

ALCOHOL CONSUMPTION; BEHAVIOR THERAPY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DRUG SAFETY; DRUG TOLERABILITY; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; LOW DRUG DOSE; METABOLIC SYNDROME X; PHYSICAL ACTIVITY; PREHYPERTENSION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; SODIUM RESTRICTION; WEIGHT REDUCTION;

EID: 84868274474     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.4061/2011/605359     Document Type: Review

References (43)

1. Chobanian A. V., Bakris G. L., Black H. R., Cushman W. C., Green L. A., Izzo J. L., Jones D. W., Materson B. J., Oparil S., Wright J. T., Roccella E. J., Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003 42 6 1206 1252 2-s2.0-0347423198 10.1161/01.HYP.0000107251.49515.c2 (Pubitemid 37553153)
2. Vasan R. S., Larson M. G., Leip E. P., Kannel W. B., Levy D., Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. The Lancet 2001 358 9294 1682 1686 2-s2.0-0035904776 10.1016/S0140-6736(01)06710-1 (Pubitemid 33124327)
3. Liszka H. A., Mainous A. G., King D. E., Everett C. J., Egan B. M., Prehypertension and cardiovascular morbidity. Annals of Family Medicine 2005 3 4 294 299 2-s2.0-23844532944 10.1370/afm.312 (Pubitemid 41176304)
4. Ferdinand K. C., Pacini R. S., New evidence confirms risks associated with prehypertension and benefits of therapeutic lifestyle changes in management. Journal of the Cardiometabolic Syndrome 2007 2 4 302 304 10.1111/j.1559-4564.2007.07620.x
5. Wang Y., Wang Q. J., The prevalence of prehypertension and hypertension among US Adults According to the New Joint National Committee Guidelines: new challenges of the old problem. Archives of Internal Medicine 2004 164 19 2126 2134 2-s2.0-6944253561 10.1001/archinte.164.19.2126 (Pubitemid 39410802)
6. Gupta A. K., McGlone M., Greenway F. L., Johnson W. D., Prehypertension in disease-free adults: a marker for an adverse cardiometabolic risk profile. Hypertension Research 2010 33 9 905 910 2-s2.0-77956411423 10.1038/hr.2010.91
7. Chrysohoou C., Pitsavos C., Panagiotakos D. B., Skoumas J., Stefanadis C., Association between prehypertension status and inflammatory markers related to atherosclerotic disease: the ATTICA Study. American Journal of Hypertension 2004 17 7 568 573 2-s2.0-3042638510 10.1016/j.amjhyper.2004.03.675 (Pubitemid 38844982)
8. Choi K. M., Park H. S., Han J. H., Lee J. S., Lee J., Ryu O. H., Lee K. W., Cho K. H., Yoon D., Baik S. H., Choi D. S., Kim S. M., Prevalence of prehypertension and hypertension in a Korean population: Korean National Health and Nutrition Survey 2001. Journal of Hypertension 2006 24 8 1515 1521 2-s2.0-33746700260 10.1097/01.hjh.0000239286.02389.0f (Pubitemid 44162452)
9. Ishikawa Y., Ishikawa J., Ishikawa S., Kayaba K., Nakamura Y., Shimada K., Kajii E., Pickering T. G., Kario K., Prevalence and determinants of prehypertension in a Japanese general population: the Jichi Medical School cohort study. Hypertension Research 2008 31 7 1323 1330 2-s2.0-55449132464 10.1291/hypres.31.1323
10. Sit J. W., Sijian L., Wong E. M., Yanling Z., Ziping W., Jianqiang J., Yanling C., Wong T. K. S., Prevalence and risk factors associated with prehypertension: identification of foci for primary prevention of hypertension. Journal of Cardiovascular Nursing 2010 25 6 461 469 2-s2.0-77958565661 10.1097/JCN.0b013e3181dcb551
11. Yang J., Lu F., Zhang C., Liu Z., Zhao Y., Gao F., Sun S., Zhao Y., Zhang Y., Prevalence of prehypertension and hypertension in a Chinese rural area from 1991 to 2007. Hypertension Research 2010 33 4 331 337 2-s2.0-77950498252 10.1038/hr.2009.235
12. Greenland K. J., Croft J. B., Mensah G. A., Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 19992000. Archives of Internal Medicine 2004 164 19 2113 2118 2-s2.0-6944225446 10.1001/archinte.164.19.2113 (Pubitemid 39410799)
13. Mainous A. R., Everett C. J., Liszka H., King D. E., Egan B. M., Prehypertension and mortality in a nationally representative cohort. American Journal of Cardiology 2004 94 12 1496 1500 2-s2.0-13944274149 10.1016/j.amjcard.2004.08.026 (Pubitemid 40268449)
14. Wu S. L., Zhang Z. Q., Song S. B., Prevalence of prehypertension and associated cardiovascular risk: two years follow up results. Chinese Journal of Epidemiology 2010 38 5 415 419
15. Isezuo S. A., Sabir A. A., Ohwovorilole A. E., Fasanmade O. A., Prevalence, associated factors and relationship between prehypertension and hypertension: a study of two ethnic African populations in Northern Nigeria. Journal of Human Hypertension 2011 25 224 230 2-s2.0-77953490687 10.1038/jhh.2010.56
16. Cordero A., Laclaustra M., León M., Grima A., Casasnovas J. A., Luengo E., Del Rio A., Ferreira I., Alegria E., Prehypertension is associated with insulin resistance state and not with an initial renal function impairment: a Metabolic Syndrome in Active Subjects in Spain (MESYAS) Registry substudy. American Journal of Hypertension 2006 19 2 189 196 2-s2.0-33644812678 10.1016/j.amjhyper.2005.08.018 (Pubitemid 43350172)
17. Zhang Y., Lee E. T., Devereux R. B., Yeh J., Best L. G., Fabsitz R. R., Howard B. V., Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the strong heart study. Hypertension 2006 47 3 410 414 2-s2.0-33644975021 10.1161/01.HYP.0000205119.19804.08 (Pubitemid 43740283)
18. Kim B. J., Lee H. J., Sung K. C., Bum S. K., Jin H. K., Man H. L., Jung R. P., Comparison of microalbuminuria in 2 blood pressure categories of prehypertensive subjects. Circulation Journal 2007 71 8 1283 1287 2-s2.0-34547563571 10.1253/circj.71.1283 (Pubitemid 47195347)
19. Chrysohoou C., Pitsavos C., Panagiotakos D. B., Skoumas J., Stefanadis C., Association between prehypertension status and inflammatory markers related to atherosclerotic disease: the ATTICA Study. American Journal of Hypertension 2004 17 7 568 573 2-s2.0-3042638510 10.1016/j.amjhyper.2004.03.675 (Pubitemid 38844982)
20. Ninomiya T., Kubo M., Doi Y., Yonemoto K., Tanizaki Y., Tsuruya K., Sueishi K., Tsuneyoshi M., Iida M., Kiyohara Y., Prehypertension increases the risk for renal arteriosclerosis in autopsies: the Hisayama study. Journal of the American Society of Nephrology 2007 18 7 2135 2142 2-s2.0-34447257961 10.1681/ASN.2007010067 (Pubitemid 47041079)
21. Marilyn B., Lawrence W., Richard B., Association of prehypertension by joint national committee 7 criteria with left ventrieulur structure and function: the strong heart study. Journal of the American College of Cardiology 2004 17 3 1142 1183
22. Kshirsagar A. V., Carpenter M., Bang H., Wyatt S. B., Colindres R. E., Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. American Journal of Medicine 2006 119 2 133 141 2-s2.0-31444436871 10.1016/j.amjmed.2005.08.023 (Pubitemid 43151479)
23. Qureshi A. I., Suri M. F., Kirmani J. F., Divani A. A., Mohammad Y., Is prehypertension a risk factor for cardiovascular diseases? Stroke 2005 36 9 1859 1863 2-s2.0-24644478073 10.1161/01.STR.0000177495.45580.f1 (Pubitemid 41266514)
24. Lewington S., Clarke R., Qizilbash N., Peto R., Collins R., Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. The Lancet 2002 360 9349 1903 1913 2-s2.0-0037079309 10.1016/S0140-6736(02)11911-8 (Pubitemid 35472129)
25. Vasan R. S., Larson M. G., Leip E. P., Kannel W. B., Levy D., Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. The Lancet 2001 358 9294 1682 1686 2-s2.0-0035904776 10.1016/S0140-6736(01)06710-1 (Pubitemid 33124327)
26. Dorjgochoo T., Shu X. O., Zhang X., Li H., Yang G., Gao L., Cai H., Gao Y. T., Zheng W., Relation of blood pressure components and categories and all-cause, stroke and coronary heart disease mortality in urban Chinese women: a population-based prospective study. Journal of Hypertension 2009 27 3 468 475 2-s2.0-67649550017 10.1097/HJH.0b013e3283220eb9
27. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., Grassi G., Heagerty A. M., Kjeldsen S. E., Laurent S., Narkiewicz K., Ruilope L., Rynkiewicz A., Schmieder R. E., Boudier H. A. J. S., Zanchetti A., 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. Journal of Hypertension 2007 25 9 1751 1762 2-s2.0-34548383480 10.1097/HJH.0b013e3282f0580f (Pubitemid 47356612)
28. Karanja N. M., Obarzanek E., Lin P. H., McCullough M. L., Phillips K. M., Swain J. F., Champagne C. M., Hoben K. P., Descriptive characteristics of the dietary patterns used in the Dietary Approaches to Stop Hypertension trial. Journal of the American Dietetic Association 1999 99 supplement 8 S19 S27 10.1016/S0002-8223(99)00412-5 (Pubitemid 29374610)
29. Sacks F. M., Svetkey L. P., Vollmer W. M., Appel L. J., Bray G. A., Harsha D., Obarzanek E., Conlin P. R., Miller III E. R., Simons-Morton D. G., Karanja N., Lin P. -H., Aickin M., Most-Windhauser M. M., Moore T. J., Proschan M. A., Cutler J. A., Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (dash) diet. New England Journal of Medicine 2001 344 1 3 10 10.1056/NEJM200101043440101 (Pubitemid 32064838)
30. Neter J. E., Stam B. E., Kok F. J., Grobbee D. E., Geleijnse J. M., Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2003 42 5 878 884 2-s2.0-0242525141 10.1161/01.HYP.0000094221.86888.AE (Pubitemid 37413724)
31. Cocco G., Pandolfi S., Physical exercise with weight reduction lowers blood pressure and improves abnormal left ventricular relaxation in pharmacologically treated hypertensive patients. Journal of Clinical Hypertension 2011 13 1 23 29 10.1111/j.1751-7176.2010.00380.x
32. Costa F. P., Machado S. H., Does the consumption of salt and food rich in sodium influence in the blood pressure of the infants? Ciencia e Saude Coletiva 2010 15 supplement 1 1383 1389 2-s2.0-78349301668
33. Miura K., Okuda N., Turin T. C., Takashima N., Nakagawa H., Nakamura K., Yoshita K., Okayama A., Ueshima H., Dietary salt intake and blood pressure in a representative Japanese population: baseline analyses of NIPPON DATA80. Journal of Epidemiology 2010 20 supplement 3 S524 S530 2-s2.0-77952306246
34. Cook N. R., Cutler J. A., Obarzanek E., Buring J. E., Rexrode K. M., Kumanyika S. K., Appel L. J., Whelton P. K., Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). British Medical Journal 2007 334 7599 885 888 2-s2.0-34247863975 10.1136/bmj.39147.604896.55 (Pubitemid 46724330)
35. Kelley G. A., Kelley K. S., Progressive resistance exercise and resting blood pressure: a meta- analysis of randomized controlled trials. Hypertension 2000 35 3 838 843 2-s2.0-0034097537 (Pubitemid 30165335)
36. Whelton S. P., Chin A., Xin X., He J., Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Annals of Internal Medicine 2002 136 7 493 503 2-s2.0-0037006994 (Pubitemid 34252283)
37. Puddey I. B., Beilin L. J., Alcohol is bad for blood pressure. Clinical and Experimental Pharmacology and Physiology 2006 33 9 847 852 2-s2.0-33747068510 10.1111/j.1440-1681.2006.04452.x (Pubitemid 44215142)
38. Elmer P. J., Obarzanek E., Vollmer W. M., Simons-Morton D., Stevens V. J., Young D. R., Lin P. H., Champagne C., Harsha D. W., Svetkey L. P., Ard J., Brantley P. J., Proschan M. A., Erlinger T. P., Appel L. J., Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-Month results of a randomized trial. Annals of Internal Medicine 2006 144 7 485 495 2-s2.0-33645800760 (Pubitemid 46780671)
39. Martin J. F., Martin L. N., Cipullo J. P., Pharmacologic treatment for prehypertension: to treat or not to treat? Recent Patents on Cardiovascular Drug Discovery 2009 4 2 133 141 2-s2.0-70149087185 10.2174/157489009788452904
40. Julius S., Nesbitt S. D., Egan B. M., Weber M. A., Michelson E. L., Kaciroti N., Black H. R., Grimm R. H., Messerli F. H., Oparil S., Schork M. A., Feasibility of treating prehypertension with an angiotensin-receptor blocker. New England Journal of Medicine 2006 354 16 1685 1697 2-s2.0-33645860811 10.1056/NEJMoa060838
41. Cadée J. A., Chang C. Y., Chen C. W., Huang C. N., Chen S. L., Wang C. K., Bovine casein hydrolysate (C12 Peptide) reduces blood pressure in prehypertensive subjects. American Journal of Hypertension 2007 20 1 1 5 2-s2.0-33845723266 10.1016/j.amjhyper.2006.06.005 (Pubitemid 46014060)
42. Fuchs F. D., Prehypertension: the rationale for early drug therapy. Cardiovascular Therapeutics 2010 28 6 339 343 2-s2.0-78449231612 10.1111/j.1755-5922.2010.00167.x
43. Pimenta E., Oparil S., Prehypertension: epidemiology, consequences and treatment. Nature Reviews Nephrology 2010 6 1 21 30 2-s2.0-74849110209 10.1038/nrneph.2009.191